<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(11)</volume><submitter>Jun SY</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The assessment of tumor-infiltrating lymphocytes (TILs) has led to the development of various immunotherapies beyond their predictive potential in gastrointestinal malignancies. However, the clinicopathologic and prognostic values of TILs have yet to be well elucidated in distal extrahepatic bile duct carcinoma (DBDC).&lt;h4>Patients and methods&lt;/h4>We evaluated stromal TILs (sTILs) and intraepithelial TILs (iTILs) in 405 surgically resected DBDCs to analyze their correlations with overall survival (OS) and recurrence-free survival (RFS) and with clinicopathologic parameters according to the eighth edition of the American Joint Committee on Cancer scheme.&lt;h4>Results&lt;/h4>High levels of sTIL density (sTIL&lt;sup>High&lt;/sup>; >5%) and iTIL count (iTIL&lt;sup>High&lt;/sup>; >3) were foun</pubmed_abstract><journal>ESMO open</journal><pagination>103969</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11575191</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prognostic value of tumor-infiltrating lymphocytes in distal extrahepatic bile duct carcinoma.</pubmed_title><pmcid>PMC11575191</pmcid><pubmed_authors>Hong SM</pubmed_authors><pubmed_authors>Kim KP</pubmed_authors><pubmed_authors>Kim JY</pubmed_authors><pubmed_authors>Jun SY</pubmed_authors><pubmed_authors>An S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic value of tumor-infiltrating lymphocytes in distal extrahepatic bile duct carcinoma.</name><description>&lt;h4>Background&lt;/h4>The assessment of tumor-infiltrating lymphocytes (TILs) has led to the development of various immunotherapies beyond their predictive potential in gastrointestinal malignancies. However, the clinicopathologic and prognostic values of TILs have yet to be well elucidated in distal extrahepatic bile duct carcinoma (DBDC).&lt;h4>Patients and methods&lt;/h4>We evaluated stromal TILs (sTILs) and intraepithelial TILs (iTILs) in 405 surgically resected DBDCs to analyze their correlations with overall survival (OS) and recurrence-free survival (RFS) and with clinicopathologic parameters according to the eighth edition of the American Joint Committee on Cancer scheme.&lt;h4>Results&lt;/h4>High levels of sTIL density (sTIL&lt;sup>High&lt;/sup>; >5%) and iTIL count (iTIL&lt;sup>High&lt;/sup>; >3) were foun</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-04-04T20:39:11.592Z</modification><creation>2025-04-04T20:39:11.592Z</creation></dates><accession>S-EPMC11575191</accession><cross_references><pubmed>39510021</pubmed><doi>10.1016/j.esmoop.2024.103969</doi></cross_references></HashMap>